Nanjing Hicin Pharmaceutical Co Ltd
SZSE:300584
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nanjing Hicin Pharmaceutical Co Ltd
SZSE:300584
|
CN |
|
Tai Hing Group Holdings Ltd
HKEX:6811
|
HK |
|
I
|
Iskandar Waterfront City Bhd
KLSE:IWCITY
|
MY |
|
L E Lundbergforetagen AB (publ)
STO:LUND B
|
SE |
|
Shenzhen Rapoo Technology Co Ltd
SZSE:002577
|
CN |
|
S
|
Suzhou Victory Precision Manufacture Co Ltd
SZSE:002426
|
CN |
|
V
|
Vedan International Holdings Ltd
HKEX:2317
|
HK |
|
R
|
Revenue Group Bhd
KLSE:REVENUE
|
MY |
|
B
|
Bittium Oyj
OMXH:BITTI
|
FI |
|
I
|
IVU Traffic Technologies AG
XETRA:IVU
|
DE |
|
G
|
Global Indemnity Group LLC
NYSE:GBLI
|
US |
Bankruptcy Probability
Nanjing Hicin Pharmaceutical Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Nanjing Hicin Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
|
Nanjing Hicin Pharmaceutical Co Ltd
SZSE:300584
|
4.9B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Nanjing Hicin Pharmaceutical Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Nanjing Hicin Pharmaceutical Co Ltd has total debt of 244.4m CNY. This includes both short-term (198.3m CNY) and long-term (46.1m CNY) debt.
You can find a full breakdown on its Balance Sheet.
